Omega Fund Management

Omega Fund Management is a private equity firm headquartered in Boston, Massachusetts, specializing in investments within the life sciences sector. The firm focuses on supporting exceptional founders and impactful products across various therapeutic areas, including oncology, immunology, rare diseases, and precision medicine. Omega Fund Management has a proven track record, having successfully brought 52 products to patients, with one public listing and eight acquisitions among the companies it has managed as an advisor to certain European funds.

The firm's investment strategy encompasses a range of stages, from early-stage ventures to late-stage and pre-IPO companies, with investment sizes typically ranging from $10 million to $50 million. Omega Fund Management's geographical focus spans North America and Western Europe, including countries such as the United States, United Kingdom, Germany, France, Switzerland, and others. The firm is dedicated to fostering innovation and advancing science to improve patient outcomes through strategic investments.

With a team that combines experience, commitment, and connections, Omega Fund Management aims to enhance the odds of success for entrepreneurs and founders in the biotech sector. The firm focuses on fostering innovation and advancing science to improve patient outcomes through strategic investments.